Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06550531
Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
Sponsor: University Hospital, Brest
View on ClinicalTrials.gov
Summary
The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination.
Official title: Impact of Human Papillomavirus Carriage on IVF/ICSI Results at Brest University Hospital
Key Details
Gender
FEMALE
Age Range
25 Years - 38 Years
Study Type
OBSERVATIONAL
Enrollment
618
Start Date
2022-02-04
Completion Date
2026-02-04
Last Updated
2024-08-13
Healthy Volunteers
No
Conditions
Locations (1)
CHRU de Brest
Brest, France